Compare Stocks: HSM, OVN, LBT, IPD, and UBI

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HSM Helius Medical Technologies		C$18.35	C$14.26 ▼ C$40.00	C$42.54M	N/A	3,578 shs	930 shs
IPD SPDR S&P International Consumer	$39.92	$0.00	$34.36 ▼ $42.84	N/A	N/A	5,198 shs	N/A

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HSM Helius Medical Technologies	0.00%	0.00%	0.00%	0.00%	0.00%
IPD SPDR S&P International Consumer	0.00%	0.00%	0.00%	0.00%	0.00%

Now Open: Crypto emergency update (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
HSM Helius Medical Technologies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IPD SPDR S&P International Consumer	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HSM Helius Medical Technologies	N/A	N/A	N/A	N/A
IPD SPDR S&P International Consumer	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HSM Helius Medical Technologies	C$477K	0.00	N/A	5.71	C$3.61 per share	0.00
IPD SPDR S&P International Consumer	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HSM Helius Medical Technologies	N/A	-C$11.02	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IPD SPDR S&P International Consumer	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
HSM Helius Medical Technologies	N/A	N/A	N/A	N/A	N/A
IPD SPDR S&P International Consumer	$0.76	1.90%	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HSM Helius Medical Technologies	0.74	4.20	3.58
IPD SPDR S&P International Consumer	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
HSM Helius Medical Technologies	N/A
IPD SPDR S&P International Consumer	N/A

Insider Ownership

Company	Insider Ownership
HSM Helius Medical Technologies	N/A
IPD SPDR S&P International Consumer	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
HSM Helius Medical Technologies	19	2.32 million	N/A	Not Optionable
IPD SPDR S&P International Consumer	N/A	N/A	N/A	Not Optionable

HSM, OVN, LBT, IPD, and UBI Headlines

Source	Headline
	S&P Global: Rebounding From Weak Ratings Business msn.com - September 4 at 10:06 AM

Media Sentiment Over Time

Company Descriptions

Helius Medical Technologies

TSE:HSM

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

SPDR S&P International Consumer

NYSEARCA:IPD

SPDR S&P International Consumer Discretionary Sector ETF (the Fund) seeks to provide investment results that correspond generally to the total return performance of the S&P Developed Ex-U.S. BMI Consumer Discretionary Sector Index (the Index), an index that tracks the consumer discretionary sector of developed global markets outside the United States. The Index represents the non-United States consumer discretionary sub-industry of developed countries included in the S&P Broad Market Index (the Global BMI Index). The Global BMI Index captures the full universe of institutionally investable stocks in developed and emerging markets with float-adjusted market capitalizations of at lease $100 million. The Fund's investment advisor is SSgA Funds Management, Inc.

Compare Stocks